BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 9, 2015
View Archived Issues
Researchers create first synthetic vascular repair graft composed of three layers
Read More
New safety data on PAT-SM6 in multiple myeloma patients
Read More
Brickell Biotech holds financing round, begins study of BBI-4000
Read More
BP-2001 reprograms intestinal cells into insulin-secreting cells in diabetes model
Read More
FDA to review sNDA for psoriasis candidate tofacitinib
Read More
Eisai updates on its Alzheimer's disease collaboration with Biogen Idec
Read More
EMA grants orphan drug status to Theravectys vaccine for ATL/L
Read More
QR Pharma and Rockefeller University collaborate to test Posiphen in HD models
Read More
Actavis to divest rights to respiratory portfolio in U.S. and Canada to AstraZeneca
Read More
Akaal Pharma reports data from phase I trial of AKP-11 in psoriasis
Read More
Isis Pharmaceuticals earns milestone payment from Biogen Idec for advancing ISIS-BIIB4Rx
Read More
UCB reports topline data from phase III program of Neupro in Parkinson's disease
Read More
Sanofi targets U.S. Lyxumia submission and LixiLan filings
Read More
Bristol-Myers Squibb discloses new IDO inhibitors
Read More
Universidad de Alcala patents treatments for leishmania and/or PTP-1B-related diseases
Read More
The University of Copenhagen patents iGluR antagonists
Read More
Inhibitors for mutant IDH2 disclosed by Agios Pharmaceuticals
Read More
Valeant amends Dendreon stalking horse asset purchase agreement
Read More
Allergan patent reports FPR2 modulators
Read More
RXi Pharmaceuticals acquires Samcyprone from Hapten Pharmaceuticals
Read More
CrystalGenomics' polmacoxib approved in South Korea for osteoarthritis
Read More
Daiichi Sankyo starts Asian phase III trial program for mirogabalin
Read More
FDA advisory committee sets March date to discuss Breo Ellipta filing
Read More
FDA approves Lucentis for diabetic retinopathy in patients with diabetic macular edema
Read More
Pfizer agrees to acquire Hospira
Read More
European Commission approves Velcade for mantle cell lymphoma
Read More
GSK files for E.U. approval of eltrombopag for treatment of chronic ITP in children
Read More
Daiichi Sankyo launches Savaysa in U.S.
Read More